Neonatal Medicine

  • 제17권1호
  • /
  • Pages.102-108
  • /
  • 2010
  • /
  • 2287-9412(pISSN)
  • /
  • 2287-9803(eISSN)
대한신생아학회 (The Korean Society of Neonatology)
권호 표지

단일기관에서 도출된 출생 후의 경피적 빌리루빈의 노모그램

Nomogram of Transcutaneous Bilirubin Level after Birth Driven from a Single Center

  • 한영지 (성애병원 소아청소년과) ;
  • 김은령 (성애병원 소아청소년과) ;
  • 이명숙 (광명성애병원 소아청소년과) ;
  • 이원욱 (광명성애병원 소아청소년과) ;
  • 박수화 (광명성애병원 소아청소년과) ;
  • 이정주 (중앙대학교 의과대학 소아청소년과)
  • Han, Young-Ji (Department of Pediatrics, Sung-Ae General Hospital) ;
  • Kim, Eun-Ryoung (Department of Pediatrics, Sung-Ae General Hospital) ;
  • Lee, Myung-Sook (Department of Pediatrics, Gwang Myang Sung-Ae General Hospital) ;
  • Lee, Won-Uk (Department of Pediatrics, Gwang Myang Sung-Ae General Hospital) ;
  • Park, Su-Hwa (Department of Pediatrics, Gwang Myang Sung-Ae General Hospital) ;
  • Lee, Jung-Ju (Department of Pediatrics, College of Medicine, Chung-Ang Uninversity)
  • 발행 : 2010.05.31
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 신생아 황달은 신생아기에 가장 흔한 질환 중 하나로 핵황달과 같은 심각한 후유증을 유발할 수 있기 때문에 조기발견과 치료가 중요하다. 본 연구에서는 경피적 황달 측정을 이용하여 황달 수치(TcB)를 측정하고 황달 수치의 변화를 노모그램으로 산출해 건강한 신생아황달의 자연경과를 살펴보고 추적 관찰과 치료가 필요한경우를 예측하고자 하였다. 방 법: 2007년 10월 1일부터 2009년 4월 30일까지 성애병원에서 출생한 재태연령 35주 이상의 건강한 만삭아와 준만삭아 중 부모가 모두 한국인인 986명을 대상으로 하였다. 출생 6시간 후부터 6시간 간격으로 퇴원시까지 경피적 황달 측정기(Minolta, JM-103)을 이용하여 이마에서 측정하였으며 이를 통해 얻어진 데이터로 노모그램을 산출하였다. 분만방법, 재태연령, 수유방법에 따른 차이를 비교하였다. 결 과 : 통계 데이터를 통해 시간에 따른 백분위수 그래프가 그려졌으며, 재태기간 35주에서 37주 6일의 신생아에서는 90 백분위수 이상, 38주 이상은 95 백분위수 이상에서 광선치료가 필요할 것으로 나타났다. 생후 24시간, 48시간, 72시간, 96시간에 TcB 수치의 평균을 분만방법, 재태연령, 수유방법에 따라 비교하였을 때 생후 48시간에서 제왕절개로 출생한 신생아가 자연분만으로 출생한 신생아에 비해 TcB 수치가 의미 있게 높았으며, 나머지 시간에서는 통계학적 의미가 없었다. 이외 수유방법에 따른 두 군의 비교에서는 모든 시간에서 통계학적 유의성이 없었다. 결 론 : 편리하고 비침습적인 경피적 황달 측정기를 이용하여 시간에 따른 TcB 수치의 변화를 노모그램을 산출하였으며 이를 이용하여 심각한 황달을 예측하는데 도움이 될 것으로 사료된다.

Purpose : The goal of this study was to measure bilirubin levels over 6 hours using a transcutaneous bilirubinometer. The change in the bilirubin levels were recorded in anomogram. The natural progress of jaundice in neonates was monitored using the nomogram and cases were identified that needed further follow-up observation and treatment. Methods : The subjects of this study were 986 healthy term or near-term infants at the age of 35 weeks or older who were born at Sung-Ae General Hospital during the period from October 1, 2007 to April 30, 2009 and whose parents were both Koreans. Transcutaneous bilirubin measurements were obtained using a transcutaneous bilirubinometer (Minolta, JM-103) from 6 hours of life to discharge at intervals of 6 hours. A nomogram was derived from the obtained data and compared to the delivery method, gestational age, and feeding method. Results : Percentile graphs were drawn according to time. Based on the graphs, phototherapy was necessary in more than 90 percent of the infants between 35 and 37.6 weeks of age and in 95 percent of the infants 38 weeks and older. The mean bilirubin level at 24, 48, 72 and 96 hours after birth were compared according to the delivery method, gestational age, and feeding method. The bilirubin level in 48 hours was significantly higher in neonates born via cesarean section delivery compared to the neonates born via vaginal delivery, however the levels were not statistically different at the other hours. Conclusion : The results of this study show the nomogram derived from hour-specific transcutaneous bilirubin levels. This information can be used to predict the risk for subsequent significant hyperbilirubinemia.

키워드

참고문헌

  1. Kliegman RM, Behrman RE, Jenson HB. Nelson textbook pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004:592-9.
  2. Smith DW, Inguillo D, Martin D, Vreman HJ, Cohen RS, Stevenson DK. Use of noninvasive tests to predict significant jaundice in full-term infants: preliminary studies. Pediatrics 1985;75:278-80.
  3. Yamauchi Y, Yamanouchi I. Clinical application of transcutaneous bilirubin measurement. Early prediction of hyperbilirubinemia. Acta Paediatr Scand 1990;79:385-90. https://doi.org/10.1111/j.1651-2227.1990.tb11481.x
  4. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14. https://doi.org/10.1542/peds.103.1.6
  5. Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of > or = 35 weeks' gestation. Pediatrics 2006;117:1169-73. https://doi.org/10.1542/peds.2005-0744
  6. Canale ST, Manugian AH. Neonatal osteomyelitis of the oscalcis: a complication of repeated heel punctures. Clin Orthop Relat Res 1981;178-82.
  7. An JR, Park SW, Lee HC, Kim KA, Ko SY, Lee YK, et al. Usefulness of the transcutaneous bilirubinometer in neonatal jaundice. Korean J Pediatr 2004;47:1287-92.
  8. Maisels MJ, Ostrea EM Jr, Touch S, Clune SE, Cepeda E, Kring E, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics 2004;113:1628-35. https://doi.org/10.1542/peds.113.6.1628
  9. Harish R, Sharma DB. Transcutaneous bilirubinometry in neonates: evaluation of Minolta Air shields jaundicemeter. Indian Pediatr 1998;35:264-7.
  10. Kim JW, Choi YH, Cha JK, Ryoo KY. Clinical significance of the transcutaneous bilirubinometry as screening test for prediction of the early neonatal jaundice. Korean J Perinatol 1999;10:30-9.
  11. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316. https://doi.org/10.1542/peds.114.1.297
  12. De Luca D, Romagnoli C, Tiberi E, Zuppa AA, Zecca E. Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr 2008;97:146-50. https://doi.org/10.1111/j.1651-2227.2007.00622.x
  13. Roh EJ, Lim JW, Cheon EJ, Ko OK. Predictive ability of predischarge transcutaneous bilirubin measurement for subsequent significant hyperbilirubinemia. J Korean Soc Neonatol 2006;13:58-67.
  14. Lee SJ, Ro HS, Kum DH. A statistical observation of neonatal jaundice. J Korean Pediatr Soc 1978;21:130-5.
  15. Choi ES, Lee CH, Yun CK. Total serum bilirubin concentration of physiologic jaundice of healthy, full-term infants. J Korean Pediatr Soc 1980;23:111-7.
  16. Maisels MJ, Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics 1998;101:995-8. https://doi.org/10.1542/peds.101.6.995
  17. Lee KS, Perlman M, Ballantyne M, Elliott I, To T. Association between duration of neonatal hospital stay and readmission rate. J Pediatr 1995;127:758-66. https://doi.org/10.1016/S0022-3476(95)70170-2
  18. Norr KF, Nacion K. Outcomes of postpartum early discharge, 1960-1986. A comparative review. Birth 1987;14:135-41. https://doi.org/10.1111/j.1523-536X.1987.tb01475.x
  19. Carty EM, Bradley CF. A randomized, controlled evaluation of early postpartum hospital discharge. Birth 1990;17:199-204. https://doi.org/10.1111/j.1523-536X.1990.tb00021.x
  20. Waldenstrom U. Early and late discharge after hospital birth: father's involvement in infant care. Early Hum Dev 1988;17:19-28. https://doi.org/10.1016/S0378-3782(88)80053-7
  21. Burgos AE, Schmitt SK, Stevenson DK, Phibbs CS. Readmission for neonatal jaundice in California, 1991-2000: trends and implications. Pediatrics 2008;121:e864-9. https://doi.org/10.1542/peds.2007-1214
  22. Sanpavat S, Nuchprayoon I, Smathakanee C, Hansuebsai R. Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. J Med Assoc Thai 2005;88:1187-93.
  23. Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child 2005;90:415-21. https://doi.org/10.1136/adc.2004.060079
  24. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 2005;159:113-9. https://doi.org/10.1001/archpedi.159.2.113
  25. Alpay F, Sarici SU, Tosuncuk HD, Serdar MA, Inanc N, Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 2000;106:E16. https://doi.org/10.1542/peds.106.2.e16
  26. Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr 2001;90:166-70. https://doi.org/10.1111/j.1651-2227.2001.tb00279.x
  27. Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2000;105:533-7. https://doi.org/10.1542/peds.105.3.533
  28. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;108:31-9. https://doi.org/10.1542/peds.108.1.31
  29. Grohmann K, Roser M, Rolinski B, Kadow I, Muller C, Goerlach-Graw A, et al. Bilirubin measurement for neonates: comparison of 9 frequently used methods. Pediatrics 2006;117:1174-83. https://doi.org/10.1542/peds.2005-0590